drugset / Trial / NCT07799493
Caplyta Versus Placebo for Adults With Social Anxiety Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this clinical trial is to learn if Caplyta works to treat Social Anxiety Disorder in adults. The main question it aims to answer is: Does Caplyta lower the frequency/severity of social anxiety symptoms in adults? Researchers will compare Caplyta to a placebo (a look-alike substance that contains no drug) to see if Caplyta works to treat Social Anxiety Disorder. Participants will: Take Caplyta or a placebo every day for 8 weeks Visit the clinic once every week for checkups and tests
Timeline
- Start
- 2026-09-10
- Primary completion
- 2028-05-18
- Completion
- 2028-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumateperone | Small molecule | 42 mg | — |